PDS Biotechnology Valuation
| EU6 Stock | EUR 1.67 0.09 5.70% |
Based on Macroaxis valuation methodology, the company appears to be fairly valued. PDS Biotechnology Corp holds a recent Real Value of €1.6 per share. The prevailing price of the company is €1.67. Our model determines the value of PDS Biotechnology Corp from inspecting the company fundamentals such as Shares Outstanding of 28.89 M, return on asset of -0.25, and Return On Equity of -0.49 as well as reviewing its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that PDS Biotechnology's price fluctuation is dangerous at this time. Calculation of the real value of PDS Biotechnology Corp is based on 3 months time horizon. Increasing PDS Biotechnology's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the PDS stock is determined by what a typical buyer is willing to pay for full or partial control of PDS Biotechnology Corp. Since PDS Biotechnology is currently traded on the exchange, buyers and sellers on that exchange determine the market value of PDS Stock. However, PDS Biotechnology's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.67 | Real 1.6 | Hype 1.67 |
The real value of PDS Stock, also known as its intrinsic value, is the underlying worth of PDS Biotechnology Corp Company, which is reflected in its stock price. It is based on PDS Biotechnology's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of PDS Biotechnology's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of PDS Biotechnology Corp helps investors to forecast how PDS stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of PDS Biotechnology more accurately as focusing exclusively on PDS Biotechnology's fundamentals will not take into account other important factors: PDS Biotechnology Total Value Analysis
PDS Biotechnology Corp is currently estimated to have takeover price of 189.69 M with market capitalization of 206 M, debt of 552.98 K, and cash on hands of 74.75 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the PDS Biotechnology fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
189.69 M | 206 M | 552.98 K | 74.75 M |
PDS Biotechnology Asset Utilization
One of the ways to look at asset utilization of PDS is to check how much profit was generated for every dollar of assets it reports. PDS Biotechnology holds a negative application of assets of -0.25 pct., losing €0.002487 for each euro of assets held by the company. Unsuccessful asset utilization implies the company is being less competent with each euro of assets it holds. Put it differently, asset utilization of PDS Biotechnology Corp shows how unproductive it operates for each euro spent on its assets.PDS Biotechnology Ownership Allocation
PDS Biotechnology owns a total of 28.89 Million outstanding shares. PDS Biotechnology holds 14.2 pct. of its outstanding shares held by insiders and 23.77 pct. owned by third-party entities. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.PDS Biotechnology Profitability Analysis
Net Loss for the year was (16.92 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates PDS Biotechnology's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in PDS Biotechnology and how it compares across the competition.
About PDS Biotechnology Valuation
The stock valuation mechanism determines PDS Biotechnology's current worth on a weekly basis. Our valuation model uses a comparative analysis of PDS Biotechnology. We calculate exposure to PDS Biotechnology's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of PDS Biotechnology's related companies.PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. PDS Biotechnology Corporation was founded in 2005 and is based in Florham Park, New Jersey. PDS BIOTECHNOLOGY operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 15 people.
8 Steps to conduct PDS Biotechnology's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates PDS Biotechnology's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct PDS Biotechnology's valuation analysis, follow these 8 steps:- Gather financial information: Obtain PDS Biotechnology's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine PDS Biotechnology's revenue streams: Identify PDS Biotechnology's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research PDS Biotechnology's industry and market trends, including the size of the market, growth rate, and competition.
- Establish PDS Biotechnology's growth potential: Evaluate PDS Biotechnology's management, business model, and growth potential.
- Determine PDS Biotechnology's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate PDS Biotechnology's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for PDS Stock analysis
When running PDS Biotechnology's price analysis, check to measure PDS Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PDS Biotechnology is operating at the current time. Most of PDS Biotechnology's value examination focuses on studying past and present price action to predict the probability of PDS Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PDS Biotechnology's price. Additionally, you may evaluate how the addition of PDS Biotechnology to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |